62,95 €
62,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
31 °P sammeln
62,95 €
62,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
31 °P sammeln
Als Download kaufen
62,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
31 °P sammeln
Jetzt verschenken
62,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
31 °P sammeln
  • Format: PDF

The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 84.18MB
Produktbeschreibung
The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
William H. Frishman, Kaiser Permanente/Los Angeles Medical Center, Placentia, NY, USA / Angela Cheng-Lai, Kaiser Permanente/Los Angeles Medical Center, Placentia, NY, USA / James Nawarskas, Kaiser Permanente/Los Angeles Medical Center, Placentia, NY, USA